Exchange Traded Concepts LLC raised its stake in Elevance Health by 58.7%, contributing to a total institutional ownership of 89.24%. Analysts favor a "Moderate Buy" with a target of $387.40, following strong Q4 earnings and a dividend increase to $1.72.

NodeGuardian

2026-04-14 10:33:39

Abstract generation in progress

Exchange Traded Concepts LLC significantly increased its stake in Elevance Health (ELV) by 58.7%, alongside other major institutional investors, pushing total institutional ownership to 89.24%. Analysts maintain a “Moderate Buy” consensus with a $387.40 target, despite recent price target trims. Elevance Health reported strong Q4 earnings, beating EPS estimates and increasing its quarterly dividend to $1.72, signaling robust operational and financial health.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
111.93K Popularity
#
GateMarchTransparencyReport
38.1K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
772.84K Popularity
#
USBlocksStraitofHormuz
745.58K Popularity
#
WCTCTradingChallengeShare8MUSDT
506.33K Popularity

Sitemap

Elevance Health, Inc. $ELV Holdings Lifted by Exchange Traded Concepts LLC

Trending Topics

GatePreIPOsLaunchesWithSpaceX

GateMarchTransparencyReport

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

WCTCTradingChallengeShare8MUSDT

Pin